Amicus Briefs Urge Court To Grant Petition Over Whether Stem Cells Are Drugs

( June 23, 2025, 1:30 PM EDT) -- WASHINGTON, D.C. — The U.S. Food and Drug Administration’s “attempts to own people’s biological cells, akin to their own skin or hair, by unjustifiably classifying them as drugs under the FDA’s regulatory scheme” is an issue of national importance, the Association of American Physicians and Surgeons (AAPS) argues in a June 20 amicus curie brief filed in the U.S. Supreme Court, urging the court to grant a petition filed by a stem cell clinic and its owners that contends that the Ninth Circuit U.S. Court of Appeals erred in finding that a stem cell mixture used by clinics is a drug under the Food, Drug and Cosmetic Act (FDCA)....